Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Iveda Solutions, Inc. (IVDA) Stock Forecast 2025 - AI Price Prediction & Analysis

Iveda Solutions, Inc. (IVDA) AI Stock Price Forecast & Investment Analysis

Iveda Solutions, Inc. Stock Price Chart and Technical Analysis

Loading Iveda Solutions, Inc. interactive price chart and technical analysis...

Iveda Solutions, Inc. (IVDA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Iveda Solutions, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Iveda Solutions, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Iveda Solutions, Inc.: Iveda Solutions, Inc. operates in the Technology sector, making it an emerging small-cap investment.

Iveda Solutions, Inc. (Stock Symbol: IVDA) is a leading company in the Technology sector , specifically operating within the Services-Prepackaged Software industry.

The organization employs approximately 55 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Iveda Solutions, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Iveda Solutions, Inc.:

Market Capitalization: $4 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Iveda Solutions, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Iveda Solutions, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Iveda Solutions, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Iveda Solutions, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Iveda Solutions, Inc.: Market positioning analysis based on available financial and operational metrics.

Iveda Solutions, Inc. strategically competes in the highly dynamic Services-Prepackaged Software marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 369.6% gross margin, indicating strong pricing power and operational efficiency.

Iveda Solutions, Inc. (IVDA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Iveda Solutions, Inc. stock analysis.

Loading Iveda Solutions, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Iveda Solutions, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Iveda Solutions, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Iveda Solutions, Inc.: With a P/E ratio of -7.46, the market sees the stock as potentially undervalued.

P/E Ratio -7.46x
P/B Ratio 0.66x
Market Cap $4M
EPS $-0.41
Book Value/Share $1.95
Revenue/Share $0.23
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Iveda Solutions, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Iveda Solutions, Inc.:

ROA -145.1%
Gross Margin 369.6%
Operating Margin -1007.0%
Net Margin -733.1%
EBT Margin -166.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Iveda Solutions, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Iveda Solutions, Inc.: A current ratio of 0.49 suggests potential liquidity concerns.

Current Ratio 0.49x
Quick Ratio 0.24x
Interest Coverage -28.0x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Iveda Solutions, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Iveda Solutions, Inc.: Free cash flow of $-2M indicates cash challenges that need attention.

Operating Cash Flow $-2M
Free Cash Flow $-2M
FCF/Sales -125.7%
CapEx/Sales 1.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Iveda Solutions, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Iveda Solutions, Inc.: An asset turnover of 0.87x suggests room for improvement in asset utilization.

Asset Turnover 0.87x
Receivables Turnover 12.4x
Inventory Turnover 1.7x
Fixed Assets Turnover 48.2x
Days Sales Outstanding 29 days
Days Inventory 219 days
Payables Period 53 days
Cash Conversion Cycle 196 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Iveda Solutions, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Iveda Solutions, Inc.:

Income Statement ($ Millions)
SG&A Expense $208M
Cost of Goods Sold $3M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 86%
Cash & Short-term Investments 36%
Total Liabilities 188%
Short-term Debt 16%
Accounts Receivable 7%
Inventory 28%
Dividend & Shareholder Information
Shares Outstanding 3M
Growth Metrics (YoY)
EPS Growth -21.0%

Latest Iveda Solutions, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Iveda Solutions, Inc. (IVDA) stock price and investment outlook.

, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

, source: The Globe and Mail

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Iveda Solutions ( (IVDA)) ...

, source: Seeking Alpha

Iveda Solutions, Inc. (IVDA) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Iveda Solutions, Inc. Competitors & Peer Analysis - Technology Sector

Comparative analysis of Iveda Solutions, Inc. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACIW Unlock Forecast - 30 Days FREE Trial $4930M 20.8x 3.5x
ADBE Unlock Forecast - 30 Days FREE Trial $141737M 21.4x 12.0x
AEYE Unlock Forecast - 30 Days FREE Trial $202M -61.5x 27.5x
AI Unlock Forecast - 30 Days FREE Trial $2320M -16.8x 2.9x
AIFF Unlock Forecast - 30 Days FREE Trial $24M -4.2x 2.0x
AISP Unlock Forecast - 30 Days FREE Trial $144M x -7.3x
ALKT Unlock Forecast - 30 Days FREE Trial $2121M -75.9x 6.1x
ALRM Unlock Forecast - 30 Days FREE Trial $2445M 20.1x 3.1x
ALSAF Unlock Forecast - 30 Days FREE Trial $45M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
AMPL Unlock Forecast - 30 Days FREE Trial $1296M -16.9x 4.6x
APCX Unlock Forecast - 30 Days FREE Trial $5M -0.8x 2.1x
API Unlock Forecast - 30 Days FREE Trial $1376M x 2.1x
APPF Unlock Forecast - 30 Days FREE Trial $9538M 64.5x 19.1x
APPN Unlock Forecast - 30 Days FREE Trial $2242M -27.3x -56.8x
ASAN Unlock Forecast - 30 Days FREE Trial $3305M -12.4x 14.7x
ATHR Unlock Forecast - 30 Days FREE Trial $72M x 12.2x
AVDX Unlock Forecast - 30 Days FREE Trial $2077M 1104.8x 3.0x
AVPT Unlock Forecast - 30 Days FREE Trial $2969M -86.5x 6.7x
AWRE Unlock Forecast - 30 Days FREE Trial $49M -8.1x 1.8x
BAND Unlock Forecast - 30 Days FREE Trial $443M -30.3x 1.1x
BASE Unlock Forecast - 30 Days FREE Trial $1354M -10.2x 10.9x
BB Unlock Forecast - 30 Days FREE Trial $2834M -11.9x 3.9x
BBAI Unlock Forecast - 30 Days FREE Trial $2326M -3.9x 8.7x
BILL Unlock Forecast - 30 Days FREE Trial $5068M -533.4x 1.3x
BKYI Unlock Forecast - 30 Days FREE Trial $5M -26.8x 0.8x
BL Unlock Forecast - 30 Days FREE Trial $3543M 37.1x 8.6x
BLIN Unlock Forecast - 30 Days FREE Trial $14M -2.4x 1.4x
BLKB Unlock Forecast - 30 Days FREE Trial $3070M 88.2x 28.4x
BMR Unlock Forecast - 30 Days FREE Trial $39M x 2.1x
BNZI Unlock Forecast - 30 Days FREE Trial $7M x 2.3x
BOX Unlock Forecast - 30 Days FREE Trial $4670M 42.9x -16.8x
BRZE Unlock Forecast - 30 Days FREE Trial $2984M -36.2x 5.0x
BSQKZ Unlock Forecast - 30 Days FREE Trial $48193M 16.5x 2.2x
BSY Unlock Forecast - 30 Days FREE Trial $16754M 68.0x 14.4x
CANG Unlock Forecast - 30 Days FREE Trial $867M x 0.2x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCCS Unlock Forecast - 30 Days FREE Trial $5417M 396.6x 2.5x
CCLD Unlock Forecast - 30 Days FREE Trial $126M 12.2x 2.3x
CCLDO Unlock Forecast - 30 Days FREE Trial $899M 79.7x 16.0x
CCRD Unlock Forecast - 30 Days FREE Trial $184M 76.0x 3.3x
CCSI Unlock Forecast - 30 Days FREE Trial $550M 6.5x -8.3x
CDNS Unlock Forecast - 30 Days FREE Trial $91715M 91.1x 17.6x
CERT Unlock Forecast - 30 Days FREE Trial $1879M 254.8x 1.8x
CFLT Unlock Forecast - 30 Days FREE Trial $7995M -15.7x 7.1x
CGNT Unlock Forecast - 30 Days FREE Trial $600M x 3.0x
CHKP Unlock Forecast - 30 Days FREE Trial $21087M x 7.6x
CLBT Unlock Forecast - 30 Days FREE Trial $4063M x 10.0x
CLOQ Unlock Forecast - 30 Days FREE Trial $28M x x
CLPS Unlock Forecast - 30 Days FREE Trial $12M x 0.7x
COUR Unlock Forecast - 30 Days FREE Trial $1373M -14.2x 2.2x
CRM Unlock Forecast - 30 Days FREE Trial $252454M 37.0x 4.1x
CRNC Unlock Forecast - 30 Days FREE Trial $428M -0.5x 2.8x
CRWD Unlock Forecast - 30 Days FREE Trial $137529M 4606.3x 36.6x
CRWV Unlock Forecast - 30 Days FREE Trial $46562M x 17.5x
CVLT Unlock Forecast - 30 Days FREE Trial $6183M 94.0x 29.4x
CWAN Unlock Forecast - 30 Days FREE Trial $4611M 12.0x 2.3x
CXM Unlock Forecast - 30 Days FREE Trial $2041M 17.1x 3.8x
CYBR Unlock Forecast - 30 Days FREE Trial $25650M x 10.8x
DAY Unlock Forecast - 30 Days FREE Trial $10990M 223.4x 4.1x
DBX Unlock Forecast - 30 Days FREE Trial $8497M 17.8x 0.0x
DDD Unlock Forecast - 30 Days FREE Trial $483M -3.9x 2.0x
DDOG Unlock Forecast - 30 Days FREE Trial $58558M 454.1x 18.3x
DH Unlock Forecast - 30 Days FREE Trial $300M -1.3x 1.0x
DOCU Unlock Forecast - 30 Days FREE Trial $14688M 51.1x 7.4x
DOMO Unlock Forecast - 30 Days FREE Trial $529M -3.7x 0.0x
DRTTF Unlock Forecast - 30 Days FREE Trial $130M 32.8x 3.8x
DSGX Unlock Forecast - 30 Days FREE Trial $7582M x 5.1x
DSNY Unlock Forecast - 30 Days FREE Trial $5M x 1.7x
DT Unlock Forecast - 30 Days FREE Trial $15231M 30.8x 5.6x
DTSS Unlock Forecast - 30 Days FREE Trial $15M -6.8x 5.2x
DUOL Unlock Forecast - 30 Days FREE Trial $12921M 132.8x 13.2x
DUOT Unlock Forecast - 30 Days FREE Trial $128M -2.8x 26.9x
EA Unlock Forecast - 30 Days FREE Trial $49773M 48.3x 8.3x
EGAN Unlock Forecast - 30 Days FREE Trial $412M 11.4x 5.1x
ESTC Unlock Forecast - 30 Days FREE Trial $9614M 11163.5x 9.9x
EVCM Unlock Forecast - 30 Days FREE Trial $2081M -59.0x 2.8x
EXFY Unlock Forecast - 30 Days FREE Trial $148M -12.3x 1.1x
FALC Unlock Forecast - 30 Days FREE Trial $12M x x
FATN Unlock Forecast - 30 Days FREE Trial $55M x 2.7x
FCUL Unlock Forecast - 30 Days FREE Trial $8M x 174.7x
FDCT Unlock Forecast - 30 Days FREE Trial $30M x 1.8x
FNGR Unlock Forecast - 30 Days FREE Trial $90M -16.8x 5.9x
FROG Unlock Forecast - 30 Days FREE Trial $5624M -60.2x 6.8x
FRSH Unlock Forecast - 30 Days FREE Trial $3330M -49.0x 3.4x
FRSX Unlock Forecast - 30 Days FREE Trial $1622M x 273.6x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1173M -8.6x 1.2x
GDYN Unlock Forecast - 30 Days FREE Trial $735M 2810.7x 1.4x
GEG Unlock Forecast - 30 Days FREE Trial $68M 5.1x 1.0x
GEGGL Unlock Forecast - 30 Days FREE Trial $645M 50.1x 9.2x
GHST Unlock Forecast - 30 Days FREE Trial $5M x x
GLBE Unlock Forecast - 30 Days FREE Trial $6160M x 6.9x
GMER Unlock Forecast - 30 Days FREE Trial $1M x x
GMGI Unlock Forecast - 30 Days FREE Trial $143M -247.8x 1.2x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0.1x x
GTLB Unlock Forecast - 30 Days FREE Trial $8433M 654.1x 9.7x
GTM Unlock Forecast - 30 Days FREE Trial $3702M x 2.4x
GWRE Unlock Forecast - 30 Days FREE Trial $19272M 305.2x 13.2x
GXAI Unlock Forecast - 30 Days FREE Trial $12M -1.3x 0.8x
HPAI Unlock Forecast - 30 Days FREE Trial $103M x 6.3x
HUBS Unlock Forecast - 30 Days FREE Trial $26065M -5033.1x 12.6x
IDAI Unlock Forecast - 30 Days FREE Trial $8M -0.7x 3.3x
IFBD Unlock Forecast - 30 Days FREE Trial $9M x 0.1x
INFA Unlock Forecast - 30 Days FREE Trial $7525M 3931.5x 3.2x
INLX Unlock Forecast - 30 Days FREE Trial $41M 1318.3x 3.6x
INSE Unlock Forecast - 30 Days FREE Trial $204M 3.6x -116.0x
INTA Unlock Forecast - 30 Days FREE Trial $3111M -173.7x 6.0x
INTU Unlock Forecast - 30 Days FREE Trial $188744M 48.9x 9.6x
IVDA Unlock Forecast - 30 Days FREE Trial $4M -7.5x 0.7x
JAMF Unlock Forecast - 30 Days FREE Trial $1707M -22.8x 2.2x
KC Unlock Forecast - 30 Days FREE Trial $45502M x 4.8x
KLTR Unlock Forecast - 30 Days FREE Trial $230M 17.7x 13.6x
KVYO Unlock Forecast - 30 Days FREE Trial $7420M -19.1x 6.8x
LAW Unlock Forecast - 30 Days FREE Trial $370M -12.7x 2.7x
LFLY Unlock Forecast - 30 Days FREE Trial $112M -0.3x -4.0x
LPSN Unlock Forecast - 30 Days FREE Trial $592M -0.5x -1.2x
MANH Unlock Forecast - 30 Days FREE Trial $10940M 52.9x 35.4x
MAPS Unlock Forecast - 30 Days FREE Trial $112M -10.7x 2.3x
MBLY Unlock Forecast - 30 Days FREE Trial $10642M -9.4x 0.9x
MDB Unlock Forecast - 30 Days FREE Trial $30095M -85.8x 10.2x
MGIC Unlock Forecast - 30 Days FREE Trial $950M x 4.5x
MKTW Unlock Forecast - 30 Days FREE Trial $38M 6.0x 0.0x
MLNK Unlock Forecast - 30 Days FREE Trial $1485M -46.1x 3.8x
MNDY Unlock Forecast - 30 Days FREE Trial $10574M x 8.9x
MQ Unlock Forecast - 30 Days FREE Trial $2163M 51.0x 2.6x
MSFT Unlock Forecast - 30 Days FREE Trial $3843601M 38.2x 10.6x
MTBLY Unlock Forecast - 30 Days FREE Trial $2486M x 51.5x
MTC Unlock Forecast - 30 Days FREE Trial $23M x x
MYPS Unlock Forecast - 30 Days FREE Trial $114M -24.1x 0.5x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0.4x 0.0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0.3x 0.5x
NABL Unlock Forecast - 30 Days FREE Trial $1473M 534.1x 1.8x
NCNO Unlock Forecast - 30 Days FREE Trial $3088M -119.0x 2.9x
NCSYF Unlock Forecast - 30 Days FREE Trial $8634M x 2.4x
NET Unlock Forecast - 30 Days FREE Trial $86223M -419.2x 64.0x
NICE Unlock Forecast - 30 Days FREE Trial $8573M x 2.4x
NOW Unlock Forecast - 30 Days FREE Trial $189680M 117.3x 16.8x
NTNX Unlock Forecast - 30 Days FREE Trial $21M 0.2x -21.5x
NTWK Unlock Forecast - 30 Days FREE Trial $49M 32.6x 1.4x
OKTA Unlock Forecast - 30 Days FREE Trial $16518M -430.9x 2.5x
ONTF Unlock Forecast - 30 Days FREE Trial $224M -6.7x 1.5x
OS Unlock Forecast - 30 Days FREE Trial $4454M x 11.5x
PATH Unlock Forecast - 30 Days FREE Trial $8605M 447.9x 5.2x
PAYC Unlock Forecast - 30 Days FREE Trial $10389M 27.2x 5.8x
PCOR Unlock Forecast - 30 Days FREE Trial $11144M -134.0x 9.2x
PCTY Unlock Forecast - 30 Days FREE Trial $7796M 37.3x 6.3x
PD Unlock Forecast - 30 Days FREE Trial $1513M -23.5x 8.4x
PDFS Unlock Forecast - 30 Days FREE Trial $1124M 1281.6x 4.4x
PDYN Unlock Forecast - 30 Days FREE Trial $289M -3.0x 5.4x
PLTR Unlock Forecast - 30 Days FREE Trial $454593M 573.7x 69.0x
PRCH Unlock Forecast - 30 Days FREE Trial $1761M 33.6x -22.8x
PRGS Unlock Forecast - 30 Days FREE Trial $1831M 40.7x 3.8x
PTC Unlock Forecast - 30 Days FREE Trial $23522M 47.8x 6.7x
QLYS Unlock Forecast - 30 Days FREE Trial $4521M 25.0x 8.9x
QTWO Unlock Forecast - 30 Days FREE Trial $3909M 798.7x 6.7x
RBLX Unlock Forecast - 30 Days FREE Trial $75563M -35.7x 185.4x
RBRK Unlock Forecast - 30 Days FREE Trial $14651M x 0.0x
RCAT Unlock Forecast - 30 Days FREE Trial $1011M -91.1x 10.6x
RDVT Unlock Forecast - 30 Days FREE Trial $742M 86.7x 7.7x
RPD Unlock Forecast - 30 Days FREE Trial $1195M 48.6x 13.2x
RPMT Unlock Forecast - 30 Days FREE Trial $49M x x
RTCJF Unlock Forecast - 30 Days FREE Trial $14M x 0.5x
S Unlock Forecast - 30 Days FREE Trial $5825M -25.6x 3.9x
SAIL Unlock Forecast - 30 Days FREE Trial $11961M -73.2x 1.8x
SBET Unlock Forecast - 30 Days FREE Trial $866M x 1.9x
SEMR Unlock Forecast - 30 Days FREE Trial $1076M 169.4x 3.9x
SHOP Unlock Forecast - 30 Days FREE Trial $226286M 975.7x 18.7x
SKIL Unlock Forecast - 30 Days FREE Trial $112M -1.4x 2.6x
SKKY Unlock Forecast - 30 Days FREE Trial $30M x 31.4x
SMSI Unlock Forecast - 30 Days FREE Trial $14M -0.2x 0.6x
SNAL Unlock Forecast - 30 Days FREE Trial $1M -7.0x 0.1x
SNOW Unlock Forecast - 30 Days FREE Trial $92553M -54.7x 39.0x
SNPS Unlock Forecast - 30 Days FREE Trial $82663M 42.3x 3.0x
SPNS Unlock Forecast - 30 Days FREE Trial $2408M x 5.0x
SPSC Unlock Forecast - 30 Days FREE Trial $3114M 51.3x 3.3x
SPT Unlock Forecast - 30 Days FREE Trial $596M -27.5x 3.2x
SSNC Unlock Forecast - 30 Days FREE Trial $20637M 25.7x 3.0x
SSTI Unlock Forecast - 30 Days FREE Trial $125M -38.0x 1.7x
SVCO Unlock Forecast - 30 Days FREE Trial $167M x 2.1x
TAOP Unlock Forecast - 30 Days FREE Trial $14M x 0.9x
TDC Unlock Forecast - 30 Days FREE Trial $2094M 18.9x 11.9x
TEAM Unlock Forecast - 30 Days FREE Trial $46307M -233.9x 33.6x
TENB Unlock Forecast - 30 Days FREE Trial $3498M -81.5x 10.0x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $8629M x 5.8x
TTWO Unlock Forecast - 30 Days FREE Trial $47142M -9.7x 13.5x
TWLO Unlock Forecast - 30 Days FREE Trial $21805M 897.7x 2.8x
TYL Unlock Forecast - 30 Days FREE Trial $22486M 80.7x 6.2x
U Unlock Forecast - 30 Days FREE Trial $15788M -13.5x 5.0x
UMEWF Unlock Forecast - 30 Days FREE Trial $37M x 1.8x
VBIX Unlock Forecast - 30 Days FREE Trial $33M x 7.2x
VEEV Unlock Forecast - 30 Days FREE Trial $47970M 59.3x 7.2x
VPRB Unlock Forecast - 30 Days FREE Trial $2M x x
VRNS Unlock Forecast - 30 Days FREE Trial $4253M -27.4x 7.0x
VWAV Unlock Forecast - 30 Days FREE Trial $31M x x
WBSR Unlock Forecast - 30 Days FREE Trial $16M x x
WEAV Unlock Forecast - 30 Days FREE Trial $508M -36.7x 6.4x
WFCF Unlock Forecast - 30 Days FREE Trial $64M 32.5x 6.5x
WHEN Unlock Forecast - 30 Days FREE Trial $55M x 40.6x
WIMI Unlock Forecast - 30 Days FREE Trial $84M x 0.1x
WK Unlock Forecast - 30 Days FREE Trial $4762M -70.2x 0.0x
XPER Unlock Forecast - 30 Days FREE Trial $295M -4.3x 0.7x
XYZ Unlock Forecast - 30 Days FREE Trial $46594M 16.7x 2.1x
YOU Unlock Forecast - 30 Days FREE Trial $2708M -51.2x 9.3x
ZDGE Unlock Forecast - 30 Days FREE Trial $34M -4.8x 1.3x
ZETA Unlock Forecast - 30 Days FREE Trial $3787M -26.5x 5.6x
ZSPC Unlock Forecast - 30 Days FREE Trial $21M x -3.2x

Frequently Asked Questions - Iveda Solutions, Inc. Stock Forecast

How accurate are Iveda Solutions, Inc. stock predictions?

Our AI model shows a 32% Spearman correlation coefficient for IVDA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Iveda Solutions, Inc. stock price forecasts?

Our analysis considers Iveda Solutions, Inc.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Iveda Solutions, Inc. a good investment in 2025?

Based on our AI analysis, Iveda Solutions, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Iveda Solutions, Inc. forecasts updated?

Iveda Solutions, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Iveda Solutions, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Iveda Solutions, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...